|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191.4 USD | -0.08% |
|
-7.00% | +11.28% |
| 25/06 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
| 24/06 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
ResMed Inc. (NYSE:RMD) is looking for tuck-in acquisitions. Brett Sandercock, Chief Financial Officer said, "we plan to continue to reinvest in growth through R&D and also expect to continue to fund future tuck-in acquisitions".
| 1st Jan change | Capi. | |
|---|---|---|
| +11.28% | 28.12B | |
| +8.00% | 185B | |
| +31.86% | 158B | |
| +33.21% | 113B | |
| +2.28% | 64.32B | |
| +21.14% | 55.66B | |
| +0.11% | 48.41B | |
| -6.76% | 37.82B | |
| +0.78% | 35.57B | |
| +15.70% | 23.58B |
RESMED, INC. 
